S, M., A, D., & KM, F. (2026). The Emerging Role of Ketamine and Esketamine in the Concurrent Management of Pain and Depression in Cancer Patients: Evidence and Implications for Practice. Journal of pain & palliative care pharmacotherapy, 40(2), 282. https://doi.org/10.1080/15360288.2025.2607541
Chicago Style (17th ed.) CitationS, Moriarty, Dushenkov A, and Frey KM. "The Emerging Role of Ketamine and Esketamine in the Concurrent Management of Pain and Depression in Cancer Patients: Evidence and Implications for Practice." Journal of Pain & Palliative Care Pharmacotherapy 40, no. 2 (2026): 282. https://doi.org/10.1080/15360288.2025.2607541.
MLA (9th ed.) CitationS, Moriarty, et al. "The Emerging Role of Ketamine and Esketamine in the Concurrent Management of Pain and Depression in Cancer Patients: Evidence and Implications for Practice." Journal of Pain & Palliative Care Pharmacotherapy, vol. 40, no. 2, 2026, p. 282, https://doi.org/10.1080/15360288.2025.2607541.